An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome
about
Probiotics and irritable bowel syndromeThe role of visceral hypersensitivity in irritable bowel syndrome: pharmacological targets and novel treatmentsRifaximin for Irritable Bowel Syndrome: A Meta-Analysis of Randomized Placebo-Controlled TrialsTowards a systems view of IBSDiagnosis of Irritable Bowel Syndrome: Role of Potential BiomarkersRegulation of the serotonin transporter in the pathogenesis of irritable bowel syndromeGut bacteria in health and diseaseThe gut-brain axis: interactions between enteric microbiota, central and enteric nervous systems.Acupuncture-moxibustion in treating irritable bowel syndrome: how does it work?The microbiota-gut-brain axis in functional gastrointestinal disorders.Irritable bowel syndrome: a microbiome-gut-brain axis disorder?Human Intestinal Barrier Function in Health and DiseaseMicrobiota in health and irritable bowel syndrome: current knowledge, perspectives and therapeutic options.Changes in the symptom pattern and the densities of large-intestinal endocrine cells following Campylobacter infection in irritable bowel syndrome: a case reportAlteration of the intestinal microbiota as a cause of and a potential therapeutic option in irritable bowel syndrome.Randomized clinical trial on the effect of a multispecies probiotic on visceroperception in hypersensitive IBS patients.Markers for visceral hypersensitivity in patients with irritable bowel syndrome.Irritable bowel syndrome: the problem and the problem of treating it - is there a role for probiotics?Mast Cell-dependent Mesenteric Afferent Activation by Mucosal Supernatant From Different Bowel Segments of Guinea Pigs With Post-infectious Irritable Bowel Syndrome.Irritable bowel syndrome: an integrated explanatory model for clinical practice.A mechanistic multicentre, parallel group, randomised placebo-controlled trial of mesalazine for the treatment of IBS with diarrhoea (IBS-D).Post-infectious irritable bowel syndrome (PI-IBS) after infection with Shiga-like toxin-producing Escherichia coli (STEC) O104:H4: A cohort study with prospective follow-upUrinary proteome analysis of irritable bowel syndrome (IBS) symptom subgroups.Functional Dyspepsia in Review: Pathophysiology and Challenges in the Diagnosis and Management due to Coexisting Gastroesophageal Reflux Disease and Irritable Bowel SyndromeA case of parasite invasion of the intestinal tract: a missed diagnosis in irritable bowel syndrome.Irritable bowel syndrome evaluation using computed tomography colonography.Therapeutic Modulation of Gut Microbiota in Functional Bowel Disorders.Characterization of antimicrobial resistance patterns and detection of virulence genes in Campylobacter isolates in Italy.Bugs on the brain; brain in the gut--seeking explanations for common gastrointestinal symptoms.The use of non-narcotic pain medication in pediatric gastroenterology.Inflammatory cytokines promote growth of intestinal smooth muscle cells by induced expression of PDGF-Rβ.Childhood functional abdominal pain: mechanisms and management.The Development of Irritable Bowel Syndrome: A Prospective Community-Based Cohort Study.Constipation: Pathophysiology and Current Therapeutic Approaches.Diagnosis and management of chronic constipation in adults.A systematic review with meta-analysis of the role of anxiety and depression in irritable bowel syndrome onset.Progress in Our Understanding of the Gut Microbiome: Implications for the Clinician.Common Functional Gastroenterological Disorders Associated With Abdominal Pain.Consensus report: faecal microbiota transfer - clinical applications and procedures.Neuroimmune factors in functional gastrointestinal disorders: A focus on irritable bowel syndrome.
P2860
Q24616349-A102D7C5-CF12-4D92-A08C-CAC2758E2956Q26739291-B481A5CF-874B-45A4-A387-B7547EDC377FQ26772962-512494E5-9968-4E2F-AAE5-157E62302C00Q26798003-521A719B-199B-4AC5-B38B-478EB1A37C4CQ26823844-D391A730-926A-4A26-B588-9FAC0CA36714Q28072085-93FF9D00-9299-4B4B-9614-8B52FDCCC02AQ28238138-BC5F8B50-722A-4B3E-8900-62402A38E61FQ30415125-53042C75-BDAB-468A-BD61-E112F06867FBQ33661084-7361DCE7-0E94-451C-8686-97CD284022D8Q34129427-AF71DCB6-BE40-45EE-ADCE-D0234BC0EA9FQ34366837-6C6B0ABA-E0DA-4A63-B7A6-7398E13ED906Q34679342-10DEB055-FF71-4823-9B41-E8975B825EBFQ34960559-4BB8AE48-0C60-40A3-BBA6-0C0A9D166046Q35001118-8E9BFFEB-D94F-409C-ADE3-C0AC4365F535Q35105259-9EEEA494-4450-42BC-959F-E447087A687FQ35109438-7C66E9F6-7C49-4926-B69E-78E2356A5D22Q35185813-8AA915E2-811A-4D98-8FD6-649371F17C68Q35231621-D1D597AB-5BC7-4AB2-B32F-31BAC130FEA6Q35430640-EC6ECEE7-1EE3-4AE0-9DA0-28080F4B6B85Q35565145-48988A80-8119-4293-885A-CA431613DAF4Q36475488-6E659FCA-BE82-4C38-8C52-209510393F76Q36616069-4FEE86F8-A897-4FFC-A410-976A5B13FD10Q36780412-E5EE9F38-BAB5-4E62-B600-39DB787E365AQ36896358-0CD5F7C5-1A66-46D5-9D64-CCD923917406Q37376014-A80B56B4-3CE5-4989-BA0D-C302AFE9B275Q37411499-2FF4578B-982F-4C31-982E-C0C7AAAEAABFQ37564122-DF4D3EAF-8D8E-4421-AB7F-FE462AEEA32AQ37644365-9C71BF7A-0550-43EA-B275-E1711904FEE6Q38062400-A4A2525A-DDDF-46BE-BB72-CEA479EEB0BAQ38221358-90E12231-E68E-4C01-BCF9-AED5B011DF1AQ38281717-8C156B20-1530-4BB4-94D5-B3E96DC1C1D4Q38349884-C2327E19-48C5-4F10-9BDA-47D2DE0F994AQ38559676-64EC9FDE-A32E-42FB-9F42-EB080AE42E9FQ38759113-E420B7D7-EA03-40FE-A3ED-030A748602B3Q38794996-4A081FC1-8397-4D83-937B-C8DF72A2B985Q38800991-D5C96C32-731D-41D1-8A5C-4E3F0A19B80DQ38905778-ADE8CA1C-FE6A-4E48-B77C-FB7D280F2CC4Q38919181-7DF514EB-AD0E-4D56-A7BF-2309A39EC689Q39021811-B9916448-ED79-4622-9F63-93254222F178Q39058964-44760DCB-D43F-44E5-B37A-F72281F77773
P2860
An Update on Post-infectious Irritable Bowel Syndrome: Role of Genetics, Immune Activation, Serotonin and Altered Microbiome
description
2012 nî lūn-bûn
@nan
2012 թուականի Յուլիսին հրատարակուած գիտական յօդուած
@hyw
2012 թվականի հուլիսին հրատարակված գիտական հոդված
@hy
2012年の論文
@ja
2012年論文
@yue
2012年論文
@zh-hant
2012年論文
@zh-hk
2012年論文
@zh-mo
2012年論文
@zh-tw
2012年论文
@wuu
name
An Update on Post-infectious I ...... rotonin and Altered Microbiome
@ast
An Update on Post-infectious I ...... rotonin and Altered Microbiome
@en
An Update on Post-infectious I ...... rotonin and Altered Microbiome
@nl
type
label
An Update on Post-infectious I ...... rotonin and Altered Microbiome
@ast
An Update on Post-infectious I ...... rotonin and Altered Microbiome
@en
An Update on Post-infectious I ...... rotonin and Altered Microbiome
@nl
prefLabel
An Update on Post-infectious I ...... rotonin and Altered Microbiome
@ast
An Update on Post-infectious I ...... rotonin and Altered Microbiome
@en
An Update on Post-infectious I ...... rotonin and Altered Microbiome
@nl
P2860
P3181
P1476
An Update on Post-infectious I ...... rotonin and Altered Microbiome
@en
P2093
P2860
P304
P3181
P356
10.5056/JNM.2012.18.3.258
P407
P577
2012-07-01T00:00:00Z